Adjuvant Chemotherapy Trial of S-1 for breast cancer with ER-positive and HER2-negative.
Phase 3
- Conditions
- Breast cancer
- Registration Number
- JPRN-UMIN000003969
- Lead Sponsor
- Department of Breast Surgery, Graduate School of Medicine, Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 1930
Inclusion Criteria
Not provided
Exclusion Criteria
1) Active double cancer 2) Bilateral (synchronous or asynchronous) breast cancer, inflammatory breast cancer 3) A history of previous treatment with oral 5-fluorouracil derivatives for 2 weeks or longer (Patients who received intravenous 5-fluorouracil can be enrolled.) 4) Serious diarrhea 5) Serious complications 6) A history of myocardial infarction within the past 6 months, interstitial pneumonia, or allergy to fluoropyrimidine derivatives 7) Pregnant women, nursing women, or women who want to become pregnant 8) Patients judged to be unsuitable for enrollment in the study by their physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Invasive Disease-free survival
- Secondary Outcome Measures
Name Time Method Overall survival Distant Disease-free survival Disease-free survival Safety